Brookdale Senior Living Inc. (BKD)
NYSE: BKD · IEX Real-Time Price · USD
6.48
-0.04 (-0.61%)
At close: Apr 19, 2024, 4:00 PM
6.75
+0.27 (4.17%)
After-hours: Apr 19, 2024, 7:59 PM EDT
Brookdale Senior Living Market Cap
Brookdale Senior Living has a market cap or net worth of $1.23 billion as of April 19, 2024. Its market cap has increased by 57.54% in one year.
Market Cap
1.23B
Enterprise Value
5.57B
1-Year Change
57.54%
Ranking
Category
Stock Price
$6.48
Market Cap Chart
Since November 22, 2005, Brookdale Senior Living's market cap has decreased from $1.65B to $1.23B, a decrease of -25.66%. That is a compound annual growth rate of -1.60%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 19, 2024 | 1.23B | -0.62% |
Apr 18, 2024 | 1.23B | 0.93% |
Apr 17, 2024 | 1.22B | 2.54% |
Apr 16, 2024 | 1.19B | -0.32% |
Apr 15, 2024 | 1.20B | -2.32% |
Apr 12, 2024 | 1.23B | -2.71% |
Apr 11, 2024 | 1.26B | -0.15% |
Apr 10, 2024 | 1.26B | -2.78% |
Apr 9, 2024 | 1.30B | -1.01% |
Apr 8, 2024 | 1.31B | 2.22% |
Apr 5, 2024 | 1.28B | 3.04% |
Apr 4, 2024 | 1.24B | -2.66% |
Apr 3, 2024 | 1.28B | 3.52% |
Apr 2, 2024 | 1.23B | -3.26% |
Apr 1, 2024 | 1.28B | 1.97% |
Mar 28, 2024 | 1.25B | 0.30% |
Mar 27, 2024 | 1.25B | 2.48% |
Mar 26, 2024 | 1.22B | -0.46% |
Mar 25, 2024 | 1.22B | 0.31% |
Mar 22, 2024 | 1.22B | -0.93% |
Mar 21, 2024 | 1.23B | 2.04% |
Mar 20, 2024 | 1.21B | -0.16% |
Mar 19, 2024 | 1.21B | 4.59% |
Mar 18, 2024 | 1.16B | 1.67% |
Mar 15, 2024 | 1.14B | 2.21% |
View and export this data all the way back to 2005.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AdaptHealth | 1.28B |
4D Molecular Therapeutics | 1.28B |
Phreesia | 1.26B |
Tarsus Pharmaceuticals | 1.26B |
Omnicell | 1.24B |
Pacira BioSciences | 1.23B |
Soleno Therapeutics | 1.23B |
Kiniksa Pharmaceuticals | 1.20B |